Fibrinolysis greater than 3% is the critical value for initiation of antifibrinolytic therapy

Journal of Trauma and Acute Care Surgery

Volumn 75, Issue 6, 2013, Pages 961-967

  Chapman, Michael P ^a,b,c   Moore, Ernest E ^a,b   Ramos, Christopher R ^a,b   Ghasabyan, Arsen ^b   Harr, Jeffrey N ^a,b   Chin, Theresa L ^a,b   Stringham, John R ^a,b   Sauaia, Angela ^a,b   Silliman, Christopher C ^d   Banerjee, Anirban ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DENVER HEALTH MEDICAL CENTER   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d Bonfils Blood Center   (United States)

Author keywords

Fibrinolysis; Massive transfusion; Mortality; Thromboelastography; Trauma

Indexed keywords

ANTIFIBRINOLYTIC AGENT; KAOLIN;

ADULT; BLEEDING; BLOOD TRANSFUSION; CONFERENCE PAPER; DRUG INDICATION; DYING; FEMALE; FIBRINOLYSIS; HUMAN; HYPERFIBRINOLYSIS; INJURY; INJURY SEVERITY; MAJOR CLINICAL STUDY; MALE; MORTALITY; PRIORITY JOURNAL; RISK FACTOR; THROMBOELASTOGRAPHY;

ADULT; ANTIFIBRINOLYTIC AGENTS; BLOOD COAGULATION DISORDERS; BLOOD TRANSFUSION; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FIBRINOLYSIS; FOLLOW-UP STUDIES; HUMANS; INJURY SEVERITY SCORE; MALE; PROGNOSIS; RETROSPECTIVE STUDIES; THROMBELASTOGRAPHY; TIME FACTORS; TREATMENT OUTCOME; WOUNDS AND INJURIES;

EID: 84890032090     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e3182aa9c9f     Document Type: Conference Paper

References (28)

1. Armand R, Hess Jr. Treating coagulopathy in trauma patients. Transfus Med Rev. 2003;17(3):223-231
2. Brohi K, Cohen MJ, Davenport RA. Acute coagulopathy of trauma: mechanism, identification and effect. Curr Opin Crit Care. 2007;13(6): 680-685
3. Brohi K, Cohen MJ, Ganter MT, Matthay MA, Mackersie RC, Pittet JF. Acute traumatic coagulopathy: initiated by hypoperfusion: modulated through the protein C pathway? Ann Surg. 2007;245(5):812-818
4. Cohen MJ. Towards hemostatic resuscitation: the changing understanding of acute traumatic biology, massive bleeding, and damage-control resuscitation. Surg Clin North Am. 2012;92(4):877-891, viii
5. Ganter MT, Pittet JF. New insights into acute coagulopathy in trauma patients. Best Pract Res Clin Anaesthesiol. 2010;24(1):15-25
6. Gonzalez EA, Moore FA, Holcomb JB, Miller CC, Kozar RA, Todd SR, et al. Freshfrozen plasma should be given earlier to patients requiring massive transfusion. J Trauma. 2007;62(1):112-119
7. Kashuk JL, Moore EE, Johnson JL, Haenel J, Wilson M, Moore JB, et al. Postinjury life threatening coagulopathy: is 1:1 fresh frozen plasma:packed red blood cells the answer? J Trauma. 2008;65(2):261-270; discussion 270-271
8. Gorlinger K, Fries D, Dirkmann D, Weber CF, Hanke AA, Schochl H. Reduction of fresh frozen plasma requirements by perioperative point-ofcare coagulation management with early calculated goal-directed therapy. Transfus Med Hemother. 2012;39(2):104-113
9. Kashuk JL, Moore EE, Sawyer M, Le T, Johnson J, Biffl WL, et al. Postinjury coagulopathy management: goal directed resuscitation via POC thrombelastography. Ann Surg. 2010;251(4):604-614
10. Schochl H, Maegele M, Solomon C, Gorlinger K, Voelckel W. Early and individualized goal-directed therapy for trauma-induced coagulopathy. Scand J Trauma Resusc Emerg Med. 2012;20:15
11. Kashuk JL, Moore EE, Sawyer M,Wohlauer M, Pezold M, Barnett C, et al. Primary fibrinolysis is integral in the pathogenesis of the acute coagulopathy of trauma. Ann Surg. 2010;252(3):434-442; discussion 443-444
12. Brohi K, Cohen MJ, Ganter MT, Schultz MJ, Levi M, Mackersie RC, et al. Acute coagulopathy of trauma: hypoperfusion induces systemic anticoagulation and hyperfibrinolysis. J Trauma. 2008;64(5):1211-1217; discussion 1217
13. CRASH-2 collaborators, Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, et al. The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. Lancet. 2011;377(9771):1096-1101, 1011.e1-1011.e2
14. collaborators C-t, Shakur H, Roberts I, Bautista R, Caballero J, Coats T, et al. Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial. Lancet. 2010;376(9734):23-32
15. Morrison JJ, Dubose JJ, Rasmussen TE, Midwinter MJ. Military Application of Tranexamic Acid in Trauma Emergency Resuscitation (MATTERs) Study. Arch Surg. 2012;147(2):113-119
16. Roberts I, Perel P, Prieto-Merino D, Shakur H, Coats T, Hunt BJ, et al. Effect of tranexamic acid on mortality in patients with traumatic bleeding: prespecified analysis of data from randomised controlled trial. BMJ. 2012; 345:e5839
17. Kutcher ME, Cripps MW, McCreery RC, Crane IM, Greenberg MD, Cachola LM, et al. Criteria for empiric treatment of hyperfibrinolysis after trauma. J Trauma Acute Care Surg. 2012;73(1):87-93
18. Haemonetics. TEG 5000 System User Manual. P/N 06-510-US, Manual revision: AC. Niles, IL: Haemonetics Corporation, Haemoscope Division; 2010
19. Cotton BA, Harvin JA, Kostousouv V, Minei KM, Radwan ZA, Schochl H, et al. Hyperfibrinolysis at admission is an uncommon but highly lethal event associated with shock and prehospital fluid administration. J Trauma Acute Care Surg. 2012;73(2):365-370; discussion 370
20. Tapia NM CA, Norman MA, Welsh FJ, Scott BG, Wall MJ, Mattox KL, Suliburk JW, eds. Hyperfibrinolysis on Thromboelastogram (TEG) Predicts Mortality in Massively Transfused Trauma Patients. Chicago, IL: American College of Surgeons; 2012:S52
21. Brown JB, Cohen MJ, Minei JP, Maier RV, West MA, Billiar TR, et al. Debunking the survival bias myth: characterization of mortality during the initial 24 hours for patients requiring massive transfusion. J Trauma Acute Care Surg. 2012;73(2):358-364; discussion 364
22. Mitra B, Cameron PA, Gruen RL, Mori A, Fitzgerald M, Street A. The definition of massive transfusion in trauma: a critical variable in examining evidence for resuscitation. Eur J Emerg Med. 2011;18(3):137-142
23. Mitra B, Rainer TH, Cameron PA. Predicting massive blood transfusion using clinical scores post-trauma. Vox Sang. 2012;102(4):324-330
24. Neal MD, Hoffman MK, Cuschieri J, Minei JP, Maier RV, Harbrecht BG, et al. Crystalloid to packed red blood cell transfusion ratio in the massively transfused patient: when a little goes a long way. J Trauma Acute Care Surg. 2012;72(4):892-898
25. Neal MD, Marsh A, Marino R, Kautza B, Raval JS, Forsythe RM, et al. Massive transfusion: an evidence-based review of recent developments. Arch Surg. 2012;147(6):563-571
26. Sperry JL, Ochoa JB, Gunn SR, Alarcon LH, Minei JP, Cuschieri J, et al. An FFP:PRBC transfusion ratio >/=1:1.5 is associated with a lower risk of mortality after massive transfusion. J Trauma. 2008;65(5):986-993
27. Morton AP, Moore EE, Wohlauer MV, Lo K, Silliman CC, Burlew CC, et al. Revisiting early postinjury mortality: are they bleeding because they are dying or dying because they are bleeding? J Surg Res. 2013; 179(1):5-9
28. Chapman MP ME, Harr JN, Wohlauer M, Ramos C, Haney E, Norem K, Omert L, Silliman CC, Banerjee A. Differential Tranexamic Acid-Inhibited Functional Fibrinogen Thromboelastography (TEG) Is a Better Guide for Anti-Fibrinolytic Therapy Than TraditionalKaolin TEG.EuropeanCongress of Trauma and Emergency Surgeons. Lyon, France: European Society of Trauma and Emergency Surgeons; 2013